Pathstone Family Office, LLC Jazz Pharmaceuticals PLC Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Pathstone Family Office, LLC holds 1,628 shares of JAZZ stock, worth $168,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,628Holding current value
$168,546% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding JAZZ
# of Institutions
513Shares Held
57MCall Options Held
65.9KPut Options Held
183K-
Black Rock Inc. New York, NY7.07MShares$732 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.45MShares$668 Million0.02% of portfolio
-
State Street Corp Boston, MA2.46MShares$255 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.38MShares$246 Million0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY1.49MShares$155 Million0.02% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $6.49B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...